<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Leading place among <z:hpo ids='HP_0000001'>all</z:hpo> postoperative complications are occupied by <z:mp ids='MP_0005048'>thrombosis</z:mp> and embolism as the cause of mortality in elderly and senile patients </plain></SENT>
<SENT sid="1" pm="."><plain>Application of existing <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> of direct (<z:chebi fb="5" ids="28304">heparin</z:chebi>) and indirect (fenilin, neodicumarin, sincumar) action is not always effective </plain></SENT>
<SENT sid="2" pm="."><plain>If is necessary to introduce in clinical practice the medicinal preparations, which possess more effective and selective antithrombotic activity </plain></SENT>
<SENT sid="3" pm="."><plain>To these requests corresponds lower molecular <z:chebi fb="5" ids="28304">heparin</z:chebi> fraxiparin (nadroparin calcium) </plain></SENT>
<SENT sid="4" pm="."><plain>For the <z:mp ids='MP_0005048'>thrombosis</z:mp> and embolism prophylaxis fraxiparin was used in 0.3 ml dose once a day subcutaneously during 3-5 days after operation </plain></SENT>
<SENT sid="5" pm="."><plain>Investigation of the blood coagulation system before and after application of fraxiparin trusted the hemostasis normalization comparing with initial tenseness of the coagulation system </plain></SENT>
<SENT sid="6" pm="."><plain>Comparative estimation of the normalization degree of the homeostasis system in patients with high risk of the <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> formation under the influence of <z:chebi fb="5" ids="28304">heparin</z:chebi> and fraxiparin high efficacy of lower molecular <z:chebi fb="5" ids="28304">heparin</z:chebi>, fraxiparin, was established </plain></SENT>
<SENT sid="7" pm="."><plain>So far as fraxiparin practically do not influence the homeostasis system negatively, it is necessary to consider him the preparation of choice in patients with an <z:hpo ids='HP_0011009'>acute</z:hpo> surgical illness and to use in the clinic of urgent surgery </plain></SENT>
<SENT sid="8" pm="."><plain>The way of fraxiparin injection performance, the lack of necessity in frequent control of the blood coagulating and anticoagulation systems allow to apply the preparation in surgical clinics of various ranking and rigging </plain></SENT>
</text></document>